| Year |
Citation |
Score |
| 2021 |
Carneiro LSA, Almeida-Souza F, Lopes YSC, Novas RCV, Santos KBA, Ligiero CBP, Calabrese KDS, Buarque CD. Synthesis of 3-aryl-4-(N-aryl)aminocoumarins via photoredox arylation and the evaluation of their biological activity. Bioorganic Chemistry. 114: 105141. PMID 34328862 DOI: 10.1016/j.bioorg.2021.105141 |
0.363 |
|
| 2018 |
da Silva VD, de Faria BM, Colombo E, Ascari L, Freitas GPA, Flores LS, Cordeiro Y, Romão L, Buarque CD. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells. Bioorganic Chemistry. 83: 87-97. PMID 30343205 DOI: 10.1016/J.Bioorg.2018.10.003 |
0.425 |
|
| 2018 |
Mendes JA, Salustiano EJ, Pires CS, Oliveira T, Barcellos JCF, Cifuentes JMC, Costa PRR, Rennó MN, Buarque CD. 11a-N-tosyl-5-carbapterocarpans: Synthesis, antineoplastic evaluation and in silico prediction of ADMETox properties. Bioorganic Chemistry. 80: 585-590. PMID 30036814 DOI: 10.1016/j.bioorg.2018.07.004 |
0.374 |
|
| 2016 |
Lemos LG, Nestal de Moraes G, Delbue D, Vasconcelos FD, Bernardo PS, Lam EW, Buarque CD, Costa PR, Maia RC. 11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes. Journal of Cancer Research and Clinical Oncology. PMID 27520309 DOI: 10.1007/s00432-016-2212-6 |
0.538 |
|
| 2014 |
Buarque CD, Salustiano EJ, Fraga KC, Alves BR, Costa PR. 11a-N-Tosyl-5-deoxi-pterocarpan (LQB-223), a promising prototype for targeting MDR leukemia cell lines. European Journal of Medicinal Chemistry. 78: 190-7. PMID 24681983 DOI: 10.1016/j.ejmech.2014.03.039 |
0.582 |
|
| 2014 |
Cortopassi WA, Penna-Coutinho J, Aguiar AC, Pimentel AS, Buarque CD, Costa PR, Alves BR, França TC, Krettli AU. Theoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparum. Plos One. 9: e91191. PMID 24651068 DOI: 10.1371/Journal.Pone.0091191 |
0.505 |
|
| 2011 |
Buarque CD, Militão GC, Lima DJ, Costa-Lotufo LV, Pessoa C, de Moraes MO, Cunha-Junior EF, Torres-Santos EC, Netto CD, Costa PR. Pterocarpanquinones, aza-pterocarpanquinone and derivatives: synthesis, antineoplasic activity on human malignant cell lines and antileishmanial activity on Leishmania amazonensis. Bioorganic & Medicinal Chemistry. 19: 6885-91. PMID 22000949 DOI: 10.1016/j.bmc.2011.09.025 |
0.585 |
|
| 2010 |
Melo PA, Pinheiro DA, Ricardo HD, Fernandes FF, Tomaz MA, El-Kik CZ, Strauch MA, da Fonseca TF, Sifuentes DN, Calil-Elias S, Buarque CD, Brito FV, Costa PR, Da Silva AJ. Ability of a synthetic coumestan to antagonize Bothrops snake venom activities. Toxicon : Official Journal of the International Society On Toxinology. 55: 488-96. PMID 19883675 DOI: 10.1016/j.toxicon.2009.09.021 |
0.486 |
|
| 2010 |
Salustiano EJ, Netto CD, Fernandes RF, da Silva AJ, Bacelar TS, Castro CP, Buarque CD, Maia RC, Rumjanek VM, Costa PR. Comparison of the cytotoxic effect of lapachol, alpha-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells. Investigational New Drugs. 28: 139-44. PMID 19255723 DOI: 10.1007/s10637-009-9231-y |
0.463 |
|
| 2006 |
Pôças ES, Lopes DV, da Silva AJ, Pimenta PH, Leitão FB, Netto CD, Buarque CD, Brito FV, Costa PR, Noël F. Structure-activity relationship of wedelolactone analogues: structural requirements for inhibition of Na+, K+ -ATPase and binding to the central benzodiazepine receptor. Bioorganic & Medicinal Chemistry. 14: 7962-6. PMID 16945543 DOI: 10.1016/J.Bmc.2006.07.053 |
0.505 |
|
| 2002 |
da Silva AJ, Buarque CD, Brito FV, Aurelian L, Macedo LF, Malkas LH, Hickey RJ, Lopes DV, Noël F, Murakami YL, Silva NM, Melo PA, Caruso RR, Castro NG, Costa PR. Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol. Bioorganic & Medicinal Chemistry. 10: 2731-8. PMID 12057662 DOI: 10.1016/S0968-0896(02)00100-1 |
0.57 |
|
| Show low-probability matches. |